Harry Dedman

489 total citations
7 papers, 346 citations indexed

About

Harry Dedman is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Harry Dedman has authored 7 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Harry Dedman's work include Sphingolipid Metabolism and Signaling (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Harry Dedman is often cited by papers focused on Sphingolipid Metabolism and Signaling (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Harry Dedman collaborates with scholars based in United States and France. Harry Dedman's co-authors include Jennifer L. Brooks, Marcus F. Boehm, Enugurthi Brahmachary, Esther Martinborough, Fiona L. Scott, Gregg Timony, Bryan Clemons, Hugh Rosen, Rachel Powell and Robert Peach and has published in prestigious journals such as Gastroenterology, Neurology and Journal of Hepatology.

In The Last Decade

Harry Dedman

7 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry Dedman United States	4	191	93	77	71	64	7	346
Hugues de Boussac France	13	214 1.1×	120 1.3×	35 0.5×	96 1.4×	107 1.7×	27	382
Masumi Yoshie Japan	8	191 1.0×	43 0.5×	48 0.6×	35 0.5×	135 2.1×	15	392
Marianna Greco Italy	13	125 0.7×	49 0.5×	90 1.2×	20 0.3×	79 1.2×	30	420
Sally A. Nicholas United Kingdom	10	270 1.4×	26 0.3×	124 1.6×	37 0.5×	51 0.8×	12	426
H Matsuzaki Japan	12	191 1.0×	81 0.9×	79 1.0×	52 0.7×	105 1.6×	28	390
Ilenia Chatziandreou Greece	11	185 1.0×	76 0.8×	31 0.4×	92 1.3×	126 2.0×	23	409
Meiyi Tang United States	12	160 0.8×	44 0.5×	193 2.5×	101 1.4×	44 0.7×	17	430
Hiromichi Nagano Japan	8	228 1.2×	32 0.3×	104 1.4×	49 0.7×	74 1.2×	9	426
John Short United Kingdom	7	217 1.1×	101 1.1×	43 0.6×	44 0.6×	101 1.6×	7	359

Countries citing papers authored by Harry Dedman

Since Specialization

Citations

This map shows the geographic impact of Harry Dedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Dedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Dedman more than expected).

Fields of papers citing papers by Harry Dedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Dedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Dedman. The network helps show where Harry Dedman may publish in the future.

Co-authorship network of co-authors of Harry Dedman

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Dedman. A scholar is included among the top collaborators of Harry Dedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Dedman. Harry Dedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wagner, Bettina, Steven P. Govek, Michael Feigh, et al.. (2017). M480, a novel non-bile acid FXR agonist, shows improvement across multiple parameters in a diet-induced obese mouse model with biopsy-confirmed NASH. Journal of Hepatology. 66(1). S433–S433. 2 indexed citations

2.

Scott, Fiona L., Bryan Clemons, Jennifer L. Brooks, et al.. (2016). Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P ₁ ) and receptor‐5 (S1P ₅ ) agonist with autoimmune disease‐modifying activity. British Journal of Pharmacology. 173(11). 1778–1792. 239 indexed citations

3.

Scott, Fiona L., Gregg Timony, Jennifer L. Brooks, et al.. (2013). Metabolites of RPC1063 Contribute to In Vivo Efficacy (P05.157). Neurology. 80(7_supplement). 4 indexed citations

4.

Brooks, Jennifer L., Robert Peach, Marcus F. Boehm, et al.. (2013). Sa1221 Rpc1063, a Potent, Selective S1P1 Receptor Modulator, Is Active in a Therapeutic IBD Model and Exhibits Favorable PK/PD Properties in Healthy Volunteers. Gastroenterology. 144(5). S–234. 3 indexed citations

5.

Clemons, Bryan, Harry Dedman, Rachel Powell, et al.. (2012). 358 A Small Molecule S1P1 Receptor Agonist With Significant Efficacy in Animal Models of Inflammatory Bowel Disease (IBD). Gastroenterology. 142(5). S–84. 1 indexed citations

6.

Bischoff, Eric D., Chris Daige, Mary Petrowski, et al.. (2010). Non-redundant roles for LXR and LXR in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. Journal of Lipid Research. 51(5). 900–906. 78 indexed citations

7.

Bischoff, Eric D., Chris Daige, Mary Petrowski, et al.. (2009). Non-redundant roles for LXRα and LXRβ in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. Journal of Lipid Research. 51(5). 900–906. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact